NPS: Medical Consequences Associated with Their Intake

Schifano, Fabrizio, Orsolini, Laura, Papanti, Duccio and Corkery, John (2016) NPS: Medical Consequences Associated with Their Intake. In: Neuropharmachology of New Psychoactive Substances (NPS): : The Science Behind the Headlines. Current Topics in Behavioral Neurosciences, 32 . Springer Nature, pp. 351-380. ISBN 978-3-319-52442-9
Copy

Over the last decade, the 'traditional' drug scene has been supplemented - but not replaced - by the emergence of a range of novel psychoactive substances (NPS), which are either newly created or existing drugs, including medications, now being used in novel ways. By the end of 2014, in excess of 500 NPS had been reported by a large number of countries in the world. Most recent data show, however, that synthetic cathinones, synthetic cannabinoids, and psychedelics/phenethylamines account for the largest number of NPS.The present chapter aims at providing an overview of the clinical and pharmacological issues relating to these most popular NPS categories. Given the vast range of medical and psychopathological issues associated with the molecules here described, it is crucial for health professionals to be aware of the effects and toxicity of NPS. A general overview of the acute management of NPS adverse events is provided as well, although further studies are required to identify a range of evidence-based, index molecule-focused, treatment strategies. The rapid pace of change in the NPS online market constitutes a major challenge to the provision of current and reliable scientific knowledge on these substances.

visibility_off description

description
revised_version_sent_out_22022016_Springer_draft_book_chapter.docx
subject
Submitted Version
lock
Restricted to Repository staff only

Request Copy

Atom BibTeX OpenURL ContextObject in Span OpenURL ContextObject Dublin Core MPEG-21 DIDL Data Cite XML EndNote HTML Citation METS MODS RIOXX2 XML Reference Manager Refer ASCII Citation
Export

Downloads